Curis | CRIS - Debt

Stock Price
0.69
Daily Change
0.07 10.92%
Monthly
-19.23%
Yearly
-46.29%
Q2 Forecast
0.49

Curis reported $0 in Debt for its fiscal quarter ending in June of 2022.





Debt Change Date
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Amgen USD 54.59B 1.62B Sep/2025
AstraZeneca USD 32.63B 207M Sep/2025
Bayer EUR 39.39B 1.31B Mar/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
CSL USD 11.96B 219M Dec/2024
Curis USD 0 0 Jun/2022
Eli Lilly USD 42.51B 2.6B Sep/2025
Exelixis USD 176.46M 3.38M Sep/2025
Gilead Sciences USD 24.94B 5M Sep/2025
GlaxoSmithKline GBP 17.75B 396M Sep/2025
Incyte USD 40.41M 855K Dec/2025
Merck USD 41.37B 5.97B Sep/2025
Novartis USD 32.64B 1.37B Jun/2025
Pfizer USD 60.85B 78M Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 21.76B 530M Sep/2025
Takeda JPY 4.85T 208B Dec/2025
TG Therapeutics USD 245.34M 8.38M Sep/2025
Verastem USD 66.79M 26.7M Sep/2024
Xoma USD 120.79M 3.27M Jun/2024